SCHEMBL15020239

SCHEMBL15020239

CCN(c1ccc(NC2=CC(=O)C(N(C)CCO)=CC2=O)cc1)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 1/20 0.38
▸ ALDH1A1 P00352 10/20 0.37
▸ HPGD P15428 3/20 0.37
▸ MAPT P10636 8/20 0.36
▸ L3MBTL1 Q9Y468 6/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ HTT P42858 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ APAF1 O14727 2/20 0.35
▸ MITF O75030 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ NR4A1 P22736 1/20 0.35
▸ SMAD3 P84022 1/20 0.35
▸ HKDC1 Q2TB90 1/20 0.35
▸ P2RX3 P56373 2/20 0.35
▸ MCL1 Q07820 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020004 0.90 DNM1 (0.37) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL16285769 0.88 DNM1 (0.40) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15039375 0.83 DNM1 (0.43) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15020240 0.81 MAPT (0.38) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15039374 0.80 DNM1 (0.61) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15039382 0.79 DNM1 (0.44) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15020195 0.78 ALDH1A1 (0.34) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15039675 0.78 ALDH1A1 (0.34) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15020197 0.78 ALDH1A1 (0.34) DNM1ALDH1A1HPGDMAPTL3MBTL1
SCHEMBL15039427 0.77 DNM1 (0.42) DNM1ALDH1A1HPGDMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2791106-B1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEROF OREAL (FR) 2016-05-18 — — EP claimed
EP-2791106-B1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEROF OREAL (FR) 2016-05-18 — — EP disclosed
US-9233057-B2 Particular quinone direct dyes, dye composition comprising at least one such dye, implementation process therefor and use thereof L'OREAL (FR) 2016-01-12 — — US disclosed
US-9233057-B2 Particular quinone direct dyes, dye composition comprising at least one such dye, implementation process therefor and use thereof L'OREAL (FR) 2016-01-12 — — US disclosed
US-20140360523-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2014-12-11 — — US disclosed
US-20140360523-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2014-12-11 — — US disclosed
EP-2791106-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2014-10-22 — — EP disclosed
WO-2013087770-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2013-06-20 — — WO disclosed
WO-2013087770-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140360523-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF KRT18, SQOR, NDUFB7 DNM1 961/4885ALDH1A1 330/4885HPGD 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback